Clinical and neuroimaging findings in MOGAD–MRI and OCT

F Bartels, A Lu, FC Oertel, C Finke… - Clinical & …, 2021 - academic.oup.com
Myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are rare in
both children and adults, and have been recently suggested to be an autoimmune …

Clinical features and imaging findings of myelin oligodendrocyte glycoprotein-IgG-associated disorder (MOGAD)

Y Li, X Liu, J Wang, C Pan, Z Tang - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein-IgG-associated disorder (MOGAD) is a nervous system
(NS) demyelination disease and a newly recognized distinct disease complicated with …

Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behçet's syndrome

A Bettiol, M Becatti, E Silvestri… - Clinical & …, 2021 - academic.oup.com
Behçet's syndrome (BS) is a systemic vasculitis with several clinical manifestations.
Neutrophil hyperactivation mediates vascular BS pathogenesis, via both a massive reactive …

Volumetric brain loss correlates with a relapsing MOGAD disease course

A Rechtman, L Brill, O Zveik, B Uliel, N Haham… - Frontiers in …, 2022 - frontiersin.org
Background Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have
evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. MOGAD …

A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course

JM Solomon, F Paul, C Chien, J Oh… - Therapeutic …, 2021 - journals.sagepub.com
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, inflammatory disease of the
central nervous system marked by relapses often associated with poor recovery and long …

Magnetic resonance imaging in neuromyelitis optica spectrum disorder

L Clarke, S Arnett, K Lilley, J Liao… - Clinical & …, 2021 - academic.oup.com
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease of the central
nervous system (CNS) associated with antibodies to aquaporin-4 (AQP4), which has distinct …

Anti-aquaporin 4 IgG is not associated with any clinical disease characteristics in neuromyelitis optica spectrum disorder

O Schmetzer, E Lakin, B Roediger, A Duchow… - Frontiers in …, 2021 - frontiersin.org
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a clinically defined,
inflammatory central nervous system (CNS) disease of unknown cause, associated with …

Volumetric brain changes in MOGAD: A cross-sectional and longitudinal comparative analysis

I Lotan, T Billiet, A Ribbens, W Van Hecke… - Multiple Sclerosis and …, 2023 - Elsevier
Background Relatively little is known about how global and regional brain volumes changes
in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) compare …

Relapse-Independent disease activity in neuromyelitis optica spectrum disorder: A systematic review

M Etemdaifar, SA Alaei, T Akaishi, M Salari… - Multiple Sclerosis and …, 2024 - Elsevier
Abstract Introduction Neuromyelitis Optica Spectrum Disorders (NMOSD) is a
neuroinflammatory condition characterized by optic neuritis and transverse myelitis. While …

Brain and spinal cord atrophy in NMOSD and MOGAD: current evidence and future perspectives.

L Lorefice, R Cortese - Multiple Sclerosis and Related Disorders, 2024 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a severe form of inflammation of the
central nervous system (CNS) including acute myelitis, optic neuritis and brain syndrome …